Clovis Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Clovis Oncology's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10% to $148,757,000. The net income raised on -$264,524,000 and profit margin reached -178%. Total operating expenses were $335,698,000.
Profit Margin
| 2012 | 0 | -73.98M | |
|---|---|---|---|
| 2013 | 0 | -84.53M | |
| 2014 | 13.62M | -160.03M | -1174.54% |
| 2015 | 0 | -352.86M | |
| 2016 | 78K | -349.13M | -447611.54% |
| 2017 | 55.51M | -346.39M | -624.02% |
| 2018 | 95.38M | -368.00M | -385.8% |
| 2019 | 143.00M | -400.42M | -280.01% |
| 2020 | 164.52M | -369.21M | -224.41% |
| 2021 | 148.75M | -264.52M | -177.82% |
CLVS Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 148.75M | 164.52M | 143.00M | 95.38M | 55.51M | 78K | 0 | 13.62M | 0 | 0 |
Cost of revenue | 38.82M | 41.30M | 34.68M | 22.07M | 11.73M | 70K | 376.72M | 158.45M | 83.76M | 0 |
Gross profit | 109.93M | 123.21M | 108.32M | 73.31M | 43.77M | 8K | -376.72M | -144.83M | -83.76M | 0 |
Operating exp. | ||||||||||
Research and development | 192.07M | 257.70M | 283.14M | 231.34M | 142.49M | 251.12M | 269.25M | 137.70M | 66.54M | 58.89M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 335.69M | 425.40M | 475.62M | 407.12M | 281.40M | 291.86M | 299.77M | 159.16M | 83.11M | 69.53M |
Operating income | -233.25M | -302.18M | -376.74M | -333.81M | -237.63M | -372.73M | -376.72M | -158.45M | -83.76M | -73.78M |
Other income (expenses), net | -31.67M | 308.92M | -21.88M | -33.58M | -112.34M | -8.43M | -5.21M | 159.89M | -713K | -228K |
Income before tax | -264.92M | -369.75M | -398.62M | -367.40M | -349.97M | -381.17M | -381.93M | -157.72M | -84.48M | -74.01M |
Income tax expense | -404K | -547K | 1.79M | 608K | -3.57M | -32.03M | -29.07M | 2.30M | 52K | -27K |
Net income | -264.52M | -369.21M | -400.42M | -368.00M | -346.39M | -349.13M | -352.86M | -160.03M | -84.53M | -73.98M |
Earnings per share | ||||||||||
Basic EPS | -2.18 | -4.38 | -7.43 | -7.07 | -7.36 | -9.07 | -9.79 | -4.72 | -2.95 | -2.97 |
Diluted EPS | -2.18 | -4.38 | -7.43 | -7.07 | -7.36 | -9.07 | -9.79 | -4.72 | -2.95 | -2.97 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |